As the market continues its march higher, investors are starting to look for the stocks that are delivering results or data that can drive share prices higher. After an almost six-year bull run, the market as a whole is expensive at 16 times earnings. While not historically off the charts, continued upside will be constrained unless higher earnings hit the tape. In a new research note, Cowen raises price targets on stocks with earnings and upside potential.
With top biotechnology and technology stocks getting some close attention from the analysts at Cowen, they are focused on companies not only delivering the goods when it comes to earnings and growth prospects, but leading their respective industries in innovation.
Here are four top stocks to buy from Cowen: BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), BroadSoft Inc. (NASDAQ: BSFT), Salesforce.com Inc. (NYSE: CRM) and Workday Inc. (NYSE: WDAY). Cowen has either raised their price targets or they have the potential for significant upside appreciation to current pricing. All are rated Outperform, as well.
The company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. Its product portfolio comprises five approved products and multiple clinical and preclinical product candidates. The Cowen analysts feel that BioMarin has an extremely attractive pipeline with three potential catalysts this year alone.
Also, past concerns about management’s ability to control costs and allow the company to become sustainably profitable are fading. The company reported strong fourth-quarter numbers with all major products ahead of consensus estimates, and guidance was right in line with expectations.
The Cowen price target is raised to $125 from $115. The Thomson/First Call consensus target is $111.28. BioMarin closed Thursday at $108.84.
Its BroadWorks platform was selected by Sprint last year to enhance voice-over-internet-protocol (VoIP) services made available by Sprint to both its consumer and business customers. The company posted strong fourth-quarter earnings and presented very solid guidance for 2015 and 2016. The Cowen team sees what they call “network transformation” projects driving near and longer term revenue ahead of the firm’s current and Wall Street forecasts, with eventual operating leverage starting next year.
Cowen raises the price target to $36 from $32, while the consensus target is posted at $31.91. The stock closed Thursday at $32.41.
This has been the momentum stock trader’s dream over the past few years. Many on Wall Street feel that while the stock trades mostly in line with its fast organic software-as-a-service (SaaS) peer group, which many see as having the largest growth rate in 2015, the company should trade at a premium to the group. The company posted year-over-year billings growth way above estimates and saw margins expand by 1.75%. The Cowen analysts see the company’s growing portfolio of enterprise-class solutions as not only enhancing the brand, but helping to achieve access into bigger companies.
Cowen raises its price target to $83 from $73. The consensus target is $70.60. Shares closed trading Thursday at $70.24.
Workday is another hot momentum stock that posted tremendous earnings and billings growth. In addition, the company guided billings growth for the first quarter and the entire year to the high end, and the Cowen team thinks the guidance is conservative.
The company is a leading provider of enterprise cloud applications for finance and human resources. Workday delivers financial management, human capital management and analytics applications designed for the world’s largest companies, educational institutions and government agencies. The analysts also feel that cloud has emerged as the future state for many large enterprises, a fact that should continue to broaden the channel of available business opportunities for Workday.
Cowen raises the price target from $99 to $111. The consensus target is set at $98.75. Some on Wall Street did not like the results, and the stock closed down a whopping 5.63% Thursday at $88.65. This could provide aggressive investors a quality entry point.
The Cowen stocks are appropriate for accounts with a high risk tolerance. With that caveat in-place, they all have incredible business models and should be solid long-term holdings.